Cluster composition

Functions

Category	Name	IntersectionWithQuery	PValue	GenesInTerm	GenesInQuery	GenesInTermInQuery	ID
GeneOntologyMolecularFunction	cAMP-dependent protein kinase activity	PRKACA PRKACB PRKACG PRKX PRKY	4.05e-10	7	146	5	GO:0004691
GeneOntologyMolecularFunction	cyclic nucleotide-dependent protein kinase activity	PRKACA PRKACB PRKACG PRKX PRKY	2.40e-09	9	146	5	GO:0004690
GeneOntologyMolecularFunction	AMP-activated protein kinase activity	PRKACA PRKACB PRKACG	4.43e-05	10	146	3	GO:0004679
GeneOntologyBiologicalProcess	embryonic epithelial tube formation	HIF1A IFT172 TSC1 WNT4 FZD6 DLC1 PRKACA PRKACB	1.70e-05	159	145	8	GO:0001838
GeneOntologyBiologicalProcess	protein kinase A signaling	PRKACA PRKACB PRKACG PRKX PRKY	2.15e-05	48	145	5	GO:0010737
GeneOntologyBiologicalProcess	primary neural tube formation	HIF1A IFT172 TSC1 FZD6 DLC1 PRKACA PRKACB	2.25e-05	120	145	7	GO:0014020
GeneOntologyBiologicalProcess	epithelial tube formation	HIF1A IFT172 TSC1 WNT4 FZD6 DLC1 PRKACA PRKACB	3.13e-05	173	145	8	GO:0072175
GeneOntologyBiologicalProcess	neural tube formation	HIF1A IFT172 TSC1 FZD6 DLC1 PRKACA PRKACB	4.58e-05	134	145	7	GO:0001841
GeneOntologyBiologicalProcess	tube formation	HIF1A IFT172 TSC1 WNT4 FZD6 DLC1 PRKACA PRKACB	5.43e-05	187	145	8	GO:0035148
GeneOntologyBiologicalProcess	morphogenesis of embryonic epithelium	HIF1A IFT172 TSC1 WNT4 FZD6 DLC1 PRKACA PRKACB	6.08e-05	190	145	8	GO:0016331
GeneOntologyBiologicalProcess	positive regulation of gluconeogenesis	SUPT20HL1 HIF1A SUPT20HL2 PRKACA	7.23e-05	32	145	4	GO:0045722
GeneOntologyBiologicalProcess	high-density lipoprotein particle assembly	PRKACA PRKACB PRKACG	9.24e-05	13	145	3	GO:0034380
GeneOntologyBiologicalProcess	positive regulation of carbohydrate metabolic process	SUPT20HL1 HIF1A SUPT20HL2 PTH1R MTOR PRKACA	9.89e-05	105	145	6	GO:0045913
GeneOntologyBiologicalProcess	neural tube closure	IFT172 TSC1 FZD6 DLC1 PRKACA PRKACB	1.48e-04	113	145	6	GO:0001843
GeneOntologyBiologicalProcess	embryonic morphogenesis	SUPT20HL1 HIF1A IFT172 HIPK1 WNT7A TSC1 SUPT20HL2 WNT4 ACVR2B DSCAML1 FZD6 DLC1 LRIG1 PRKACA PRKACB	1.54e-04	713	145	15	GO:0048598
GeneOntologyBiologicalProcess	tube closure	IFT172 TSC1 FZD6 DLC1 PRKACA PRKACB	1.56e-04	114	145	6	GO:0060606
GeneOntologyBiologicalProcess	negative regulation of TOR signaling	HIF1A TSC1 PRKACA PRKACB SEC13	1.75e-04	74	145	5	GO:0032007
GeneOntologyCellularComponent	cAMP-dependent protein kinase complex	PRKACA PRKACB PRKACG	3.79e-05	10	145	3	GO:0005952
HumanPheno	Neonatal short-limb short stature	PTH1R PRKACA PRKACB COL1A2	4.99e-06	14	45	4	HP:0008921
HumanPheno	Short limb dwarfism	PTH1R PRKACA PRKACB COL1A2	1.87e-05	19	45	4	HP:0003505
HumanPheno	Dwarfism	PTH1R PRKACA PRKACB COL1A2	2.85e-05	21	45	4	HP:0001516
Domain	WD40_repeat_CS	KIF21A EML6 TBL3 BRWD3 TLE2 CSTF1 TAF5L CORO7 ATG16L2	4.59e-06	164	142	9	IPR019775
Domain	WD40	IFT172 KIF21A EML6 TBL3 BRWD3 TLE2 CSTF1 TAF5L CORO7 ATG16L2 SEC13	4.74e-06	259	142	11	PF00400
Domain	WD40	IFT172 KIF21A EML6 TBL3 BRWD3 TLE2 CSTF1 TAF5L CORO7 ATG16L2 SEC13	6.56e-06	268	142	11	SM00320
Domain	WD40_repeat	IFT172 KIF21A EML6 TBL3 BRWD3 TLE2 CSTF1 TAF5L CORO7 ATG16L2 SEC13	7.55e-06	272	142	11	IPR001680
Domain	WD_REPEATS_1	IFT172 KIF21A EML6 TBL3 BRWD3 TLE2 CSTF1 TAF5L CORO7 ATG16L2 SEC13	9.28e-06	278	142	11	PS00678
Domain	WD_REPEATS_2	IFT172 KIF21A EML6 TBL3 BRWD3 TLE2 CSTF1 TAF5L CORO7 ATG16L2 SEC13	9.60e-06	279	142	11	PS50082
Domain	WD_REPEATS_REGION	IFT172 KIF21A EML6 TBL3 BRWD3 TLE2 CSTF1 TAF5L CORO7 ATG16L2 SEC13	9.60e-06	279	142	11	PS50294
Domain	WD40_repeat_dom	IFT172 KIF21A EML6 TBL3 BRWD3 TLE2 CSTF1 TAF5L CORO7 ATG16L2 SEC13	1.72e-05	297	142	11	IPR017986
Domain	-	IFT172 KIF21A EML6 TBL3 BRWD3 TLE2 CSTF1 TAF5L CORO7 ATG16L2 SEC13	4.90e-05	333	142	11	2.130.10.10
Domain	WD40/YVTN_repeat-like_dom	IFT172 KIF21A EML6 TBL3 BRWD3 TLE2 CSTF1 TAF5L CORO7 ATG16L2 SEC13	5.17e-05	335	142	11	IPR015943
Domain	AGC-kinase_C	MAST2 PRKACA PRKACB PRKACG PRKX	6.62e-05	56	142	5	IPR000961
Domain	AGC_KINASE_CTER	MAST2 PRKACA PRKACB PRKACG PRKX	6.62e-05	56	142	5	PS51285
Domain	S_TK_X	MAST2 PRKACA PRKACB PRKACG PRKX	6.62e-05	56	142	5	SM00133
Domain	GPR1/GPR3/GPR5	ADGRG5 ADGRG2	3.41e-04	4	142	2	IPR003910
Pathway	REACTOME_CREB1_PHOSPHORYLATION_THROUGH_THE_ACTIVATION_OF_ADENYLATE_CYCLASE	PRKACA PRKACB PRKACG PRKX	1.66e-06	12	110	4	M27363
Pathway	KEGG_VIBRIO_CHOLERAE_INFECTION	ATP6V1A ERO1A PRKACA PRKACB PRKACG PRKX	3.75e-06	54	110	6	M17906
Pathway	KEGG_MEDICUS_REFERENCE_PTH_PTH1R_PKA_SIGNALING_PATHWAY	PTH1R PRKACA PRKACB PRKACG	4.48e-06	15	110	4	M47504
Pathway	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_KEY_METABOLIC_FACTORS	PRKACA PRKACB PRKACG	4.57e-06	5	110	3	M26988
Pathway	KEGG_HEDGEHOG_SIGNALING_PATHWAY	WNT7A WNT4 PRKACA PRKACB PRKACG PRKX	4.65e-06	56	110	6	M1053
Pathway	KEGG_MELANOGENESIS	WNT7A WNT4 FZD6 PRKACA PRKACB PRKACG PRKX	1.37e-05	101	110	7	M7761
Pathway	REACTOME_PKA_MEDIATED_PHOSPHORYLATION_OF_CREB	PRKACA PRKACB PRKACG PRKX	1.54e-05	20	110	4	M759
Pathway	KEGG_MEDICUS_REFERENCE_PKA_HOLOENZYME	PRKACA PRKACB PRKACG	1.58e-05	7	110	3	M47896
Pathway	REACTOME_HDL_ASSEMBLY	PRKACA PRKACB PRKACG	2.52e-05	8	110	3	M27840
Pathway	REACTOME_ROBO_RECEPTORS_BIND_AKAP5	PRKACA PRKACB PRKACG	3.75e-05	9	110	3	M27877
Pathway	WP_POLYCYSTIC_KIDNEY_DISEASE_PATHWAY	WNT7A TSC1 WNT4 FZD6 MTOR PRKACG	5.22e-05	85	110	6	M48315
Pathway	KEGG_MEDICUS_REFERENCE_AVP_V2R_PKA_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	5.33e-05	10	110	3	M47648
Pathway	WP_DYSREGULATED_MIRNA_TARGETING_IN_INSULINPI3KAKT_SIGNALING	MTOR PRKX PRKY COL1A2	6.22e-05	28	110	4	MM15957
Pathway	KEGG_GAP_JUNCTION	TUBA4A TUBA1B PRKACA PRKACB PRKACG PRKX	7.20e-05	90	110	6	M4013
Pathway	REACTOME_ACTIVATION_OF_NMDA_RECEPTORS_AND_POSTSYNAPTIC_EVENTS	TUBA4A TUBA1B PRKACA PRKACB PRKACG PRKX	9.18e-05	94	110	6	M2843
Pathway	REACTOME_REGULATION_OF_GLYCOLYSIS_BY_FRUCTOSE_2_6_BISPHOSPHATE_METABOLISM	PRKACA PRKACB PRKACG	9.66e-05	12	110	3	M27950
Pathway	KEGG_INSULIN_SIGNALING_PATHWAY	HK1 TSC1 MTOR PRKACA PRKACB PRKACG PRKX	9.72e-05	137	110	7	M18155
Pathway	WP_DOPAMINE_METABOLISM	PRKACA PRKACB PRKACG	1.25e-04	13	110	3	M39622
Pathway	KEGG_PRION_DISEASES	PRKACA PRKACB PRKACG PRKX	1.53e-04	35	110	4	M13036
Pathway	WP_MODULATION_OF_PI3KAKTMTOR_SIGNALING_BY_BIOACTIVE_SPHINGOLIPIDS	HIF1A TSC1 MTOR	1.58e-04	14	110	3	M45553
Pathway	REACTOME_SIGNALING_BY_HEDGEHOG	IFT172 TUBA4A TUBA1B PRKACA PRKACB PRKACG SPOP	1.71e-04	150	110	7	M27440
Pathway	KEGG_WNT_SIGNALING_PATHWAY	WNT7A WNT4 FZD6 PRKACA PRKACB PRKACG PRKX	1.78e-04	151	110	7	M19428
Pathway	REACTOME_CA_DEPENDENT_EVENTS	PRKACA PRKACB PRKACG PRKX	1.90e-04	37	110	4	M749
Pathway	KEGG_MEDICUS_REFERENCE_EP_NE_ADRB_CAMP_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	1.96e-04	15	110	3	M47794
Pathway	KEGG_MEDICUS_REFERENCE_DRD1_GNAS_AC_PKA_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	2.40e-04	16	110	3	M47551
Pathway	KEGG_MEDICUS_REFERENCE_LHCGR_GNAS_PKA_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	2.40e-04	16	110	3	M47645
Pathway	KEGG_MEDICUS_REFERENCE_FSHR_GNAS_PKA_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	2.40e-04	16	110	3	M47650
Pathway	REACTOME_RAP1_SIGNALLING	PRKACA PRKACB PRKACG	2.40e-04	16	110	3	M923
Pathway	REACTOME_HEDGEHOG_OFF_STATE	IFT172 TUBA4A TUBA1B PRKACA PRKACB PRKACG	2.53e-04	113	110	6	M27471
Pathway	REACTOME_DAG_AND_IP3_SIGNALING	PRKACA PRKACB PRKACG PRKX	2.85e-04	41	110	4	M512
Pathway	REACTOME_PKA_ACTIVATION_IN_GLUCAGON_SIGNALLING	PRKACA PRKACB PRKACG	2.90e-04	17	110	3	M26995
Pathway	KEGG_MEDICUS_REFERENCE_CX3CR1_GNAI_AC_PKA_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	2.90e-04	17	110	3	M47544
Pathway	WP_HEDGEHOG_SIGNALING_WP4249	PRKACA PRKACB PRKACG SPOP	3.43e-04	43	110	4	M39706
Pathway	REACTOME_ADORA2B_MEDIATED_ANTI_INFLAMMATORY_CYTOKINES_PRODUCTION	PRKACA PRKACB PRKACG PRKX	3.43e-04	43	110	4	M29837
Pathway	KEGG_VASOPRESSIN_REGULATED_WATER_REABSORPTION	PRKACA PRKACB PRKACG PRKX	3.75e-04	44	110	4	M9011
Pathway	REACTOME_PLASMA_LIPOPROTEIN_ASSEMBLY	PRKACA PRKACB PRKACG	4.09e-04	19	110	3	M27841
Pathway	KEGG_PROGESTERONE_MEDIATED_OOCYTE_MATURATION	CCNB2 PRKACA PRKACB PRKACG PRKX	5.27e-04	85	110	5	M3578
Pathway	REACTOME_GLUCOSE_METABOLISM	HK1 PRKACA PRKACB PRKACG SEC13	5.27e-04	85	110	5	M1870
Pathway	REACTOME_CD209_DC_SIGN_SIGNALING	PRKACA PRKACB PRKACG	5.55e-04	21	110	3	M27485
Pathway	KEGG_MEDICUS_REFERENCE_MICROTUBULE_RHOA_SIGNALING_PATHWAY	TUBA4A TUBA1B ARHGEF2	5.55e-04	21	110	3	M47767
Pathway	REACTOME_SIGNALING_BY_HEDGEHOG	IFT172 TUBA4A TUBA1B PRKACA PRKACB SPOP	7.07e-04	137	110	6	MM15182
Pathway	KEGG_TASTE_TRANSDUCTION	PRKACA PRKACB PRKACG PRKX	7.12e-04	52	110	4	M5785
Pathway	WP_THYROID_HORMONES_PRODUCTION_AND_PERIPHERAL_DOWNSTREAM_SIGNALING_EFFECTS	TSC1 WNT4 SLCO1C1 MTOR PRKACA	7.95e-04	93	110	5	M39791
Pathway	REACTOME_G_PROTEIN_MEDIATED_EVENTS	PRKACA PRKACB PRKACG PRKX	8.22e-04	54	110	4	M26911
Pathway	REACTOME_TRIGLYCERIDE_CATABOLISM	PRKACA PRKACB PRKACG	8.30e-04	24	110	3	M10064
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	8.30e-04	24	110	3	M47520
Pathway	REACTOME_DARPP_32_EVENTS	PRKACA PRKACB PRKACG	8.30e-04	24	110	3	M751
Pathway	BIOCARTA_CPSF_PATHWAY	CSTF1 CPSF1	8.87e-04	6	110	2	MM1561
Pathway	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	PRKACA PRKACB	8.87e-04	6	110	2	MM14628
Pathway	KEGG_MEDICUS_PATHOGEN_HCMV_UL33_TO_GNAI_AC_PKA_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	1.05e-03	26	110	3	M47553
Pathway	PID_IL3_PATHWAY	PRKACA PRKACB PRKACG	1.05e-03	26	110	3	M182
Pathway	KEGG_MEDICUS_REFERENCE_CRHR_PKA_ACTH_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	1.18e-03	27	110	3	M47518
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_INACTIVATED_RASD1_TO_CRHR_PKA_ACTH_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	1.18e-03	27	110	3	M47519
Pathway	REACTOME_HDL_ASSEMBLY	PRKACA PRKACB	1.24e-03	7	110	2	MM15560
Pathway	WP_WNT_SIGNALING	WNT7A WNT4 FZD6 PLAU	1.30e-03	61	110	4	MM15893
Pathway	KEGG_MEDICUS_REFERENCE_GHRHR_PKA_GH_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	1.31e-03	28	110	3	M47647
Pathway	BIOCARTA_NO1_PATHWAY	PDE2A PRKACB PRKACG	1.31e-03	28	110	3	M4383
Pathway	REACTOME_HEDGEHOG_OFF_STATE	IFT172 TUBA4A TUBA1B PRKACA PRKACB	1.37e-03	105	110	5	MM15206
Pathway	WP_LIPID_METABOLISM_PATHWAY	PRKACA PRKACB PRKACG	1.46e-03	29	110	3	M39762
Pathway	KEGG_MEDICUS_REFERENCE_TSH_TG_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	1.46e-03	29	110	3	M47627
Pathway	WP_CANNABINOID_RECEPTOR_SIGNALING	PRKACA PRKACB PRKACG	1.46e-03	29	110	3	M39676
Pathway	KEGG_MEDICUS_VARIANT_MUTATION_ACTIVATED_GNAS_TO_ACTH_CORTISOL_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	1.46e-03	29	110	3	M47515
Pathway	WP_THERMOGENESIS	TSC1 MTOR PRKACA PRKACB PRKACG	1.56e-03	108	110	5	M39746
Pathway	WP_GPR143_IN_MELANOCYTES_AND_RETINAL_PIGMENT_EPITHELIUM_CELLS	PRKACA PRKACB PRKACG	1.61e-03	30	110	3	M42578
Pathway	KEGG_MEDICUS_VARIANT_CYP11B1_CYP11B2_FUSION_TO_ACTH_CORTISOL_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	1.77e-03	31	110	3	M47507
Pathway	WP_AMPACTIVATED_PROTEIN_KINASE_SIGNALING	TSC1 MTOR PRKACB PRKACG	1.84e-03	67	110	4	M39630
Pathway	KEGG_OOCYTE_MEIOSIS	CCNB2 PRKACA PRKACB PRKACG PRKX	1.90e-03	113	110	5	M16817
Pathway	KEGG_MEDICUS_REFERENCE_ACTH_CORTISOL_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	1.94e-03	32	110	3	M47506
Pathway	REACTOME_NUCLEAR_ENVELOPE_NE_REASSEMBLY	TUBA4A TUBA1B CCNB2 SEC13	1.95e-03	68	110	4	MM14921
Pathway	WP_CARDIOMYOCYTE_SIGNALING_CONVERGING_ON_TITIN	PRKACA PRKACB PRKACG	2.13e-03	33	110	3	M48071
Pathway	REACTOME_GLUCAGON_SIGNALING_IN_METABOLIC_REGULATION	PRKACA PRKACB PRKACG	2.13e-03	33	110	3	M11575
Pathway	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION	KIF21A TUBA4A TUBA1B PRKACA PRKACB	2.13e-03	116	110	5	MM15715
Pathway	REACTOME_FACTORS_INVOLVED_IN_MEGAKARYOCYTE_DEVELOPMENT_AND_PLATELET_PRODUCTION	KIF21A TUBA4A TUBA1B PRKACA PRKACB PRKACG	2.15e-03	170	110	6	M941
Pathway	KEGG_LONG_TERM_POTENTIATION	PRKACA PRKACB PRKACG PRKX	2.17e-03	70	110	4	M3115
Pathway	WP_EMBRYONIC_STEM_CELL_PLURIPOTENCY_PATHWAYS	WNT7A WNT4 ACVR2B FZD6 MTOR	2.21e-03	117	110	5	M39530
Pathway	KEGG_MEDICUS_REFERENCE_ADRB3_UCP1_SIGNALING_PATHWAY	PRKACA PRKACB PRKACG	2.52e-03	35	110	3	M47969
Pathway	BIOCARTA_CPSF_PATHWAY	CSTF1 CPSF1	2.61e-03	10	110	2	M22041
Pathway	REACTOME_SIGNALING_BY_NOTCH1	APH1B HIF1A TLE2 NEURL1	2.65e-03	74	110	4	M616
Pathway	WP_WNT_SIGNALING_IN_KIDNEY_DISEASE	WNT7A WNT4 FZD6	2.74e-03	36	110	3	M39699
Pathway	PID_GMCSF_PATHWAY	PRKACA PRKACB PRKACG	2.74e-03	36	110	3	M22
Pubmed	Molecular cloning of a tissue-specific protein kinase (C gamma) from human testis--representing a third isoform for the catalytic subunit of cAMP-dependent protein kinase.	PRKACA PRKACB PRKACG	7.86e-08	3	150	3	2342480
Pubmed	The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits.	PRKACA PRKACB PRKACG	7.86e-08	3	150	3	19383776
Pubmed	Active cAMP-dependent protein kinase incorporated within highly purified HIV-1 particles is required for viral infectivity and interacts with viral capsid protein.	PRKACA PRKACB PRKACG	7.86e-08	3	150	3	12842892
Pubmed	Amplification of the angiogenic signal through the activation of the TSC/mTOR/HIF axis by the KSHV vGPCR in Kaposi's sarcoma.	HIF1A TSC1 MTOR	7.86e-08	3	150	3	21559457
Pubmed	Hypoxia regulates Hippo signalling through the SIAH2 ubiquitin E3 ligase.	HIF1A HIPK1 OGDHL SH3RF3	1.60e-07	12	150	4	25438054
Pubmed	GPCR signaling inhibits mTORC1 via PKA phosphorylation of Raptor.	MTOR PRKACA PRKACB	3.14e-07	4	150	3	31112131
Pubmed	Protein kinase A-induced phosphorylation of the p65 subunit of nuclear factor-kappaB promotes Schwann cell differentiation into a myelinating phenotype.	PRKACA PRKACB PRKACG	3.14e-07	4	150	3	18385332
Pubmed	HIV-1 Tat binds to SH3 domains: cellular and viral outcome of Tat/Grb2 interaction.	PRKACA PRKACB PRKACG	7.81e-07	5	150	3	21745501
Pubmed	HIV-1 gp120 induces anergy in naive T lymphocytes through CD4-independent protein kinase-A-mediated signaling.	PRKACA PRKACB PRKACG	7.81e-07	5	150	3	12972513
Pubmed	Overexpressing PKIB in prostate cancer promotes its aggressiveness by linking between PKA and Akt pathways.	PRKACA PRKACB PRKACG	7.81e-07	5	150	3	19483721
Pubmed	Effects of [D-Ala1] peptide T-NH2 and HIV envelope glycoprotein gp120 on cyclic AMP dependent protein kinases in normal and psoriatic human fibroblasts.	PRKACA PRKACB PRKACG	7.81e-07	5	150	3	9540970
Pubmed	PKA-mediated stabilization of FoxH1 negatively regulates ERalpha activity.	PRKACA PRKACB PRKACG	7.81e-07	5	150	3	19711044
Pubmed	Architectural DNA-binding properties of the spermatidal transition proteins 1 and 2.	PRKACA PRKACB PRKACG	1.56e-06	6	150	3	9837753
Pubmed	Ser276 phosphorylation of NF-kB p65 by MSK1 controls SCF expression in inflammation.	PRKACA PRKACB PRKACG	1.56e-06	6	150	3	19197368
Pubmed	Dynamic binding of PKA regulatory subunit RI alpha.	PRKACA PRKACB PRKACG	2.72e-06	7	150	3	16407073
Pubmed	Phosphorylation of HIV Nef by cAMP-dependent protein kinase.	PRKACA PRKACB PRKACG	2.72e-06	7	150	3	15629779
Pubmed	CCL3L1 prevents gp120-induced neuron death via the CREB cell signaling pathway.	PRKACA PRKACB PRKACG	4.33e-06	8	150	3	19100722
Pubmed	Bicc1 links the regulation of cAMP signaling in polycystic kidneys to microRNA-induced gene silencing.	PRKACA PRKX PRKY	4.33e-06	8	150	3	22641646
Pubmed	Transcriptional activation of the NF-kappaB p65 subunit by mitogen- and stress-activated protein kinase-1 (MSK1).	PRKACA PRKACB PRKACG	4.33e-06	8	150	3	12628924
Pubmed	Human immunodeficiency virus proteins induce the inhibitory cAMP/protein kinase A pathway in normal lymphocytes.	PRKACA PRKACB PRKACG	6.48e-06	9	150	3	7688126
Pubmed	HIV-1 Tat-peptide inhibits protein kinase C and protein kinase A through substrate competition.	PRKACA PRKACB PRKACG	9.23e-06	10	150	3	20433920
Pubmed	A deep proteomics perspective on CRM1-mediated nuclear export and nucleocytoplasmic partitioning.	RAPGEF6 ETV3 PDCD2L TUBA4A TRIM5 TUBA1B MTOR CCNB2 PRKACA PRKACB CRYBG1 KATNIP IK PRKX ATG16L2 SEC13	1.15e-05	1038	150	16	26673895
Pubmed	RNA-binding proteins with basic-acidic dipeptide (BAD) domains self-assemble and aggregate in Alzheimer's disease.	DDX31 POLR2L RPS20 XAB2 TUBA1B SAFB KIN LTN1 CSTF1 CPSF1 ARHGEF2 IK GNL3	1.42e-05	713	150	13	29802200
Pubmed	PKA phosphorylation dissociates FKBP12.6 from the calcium release channel (ryanodine receptor): defective regulation in failing hearts.	PRKACA PRKACB PRKACG	1.68e-05	12	150	3	10830164
Pubmed	Network organization of the huntingtin proteomic interactome in mammalian brain.	ATP6V1A PDE2A STAB2 HK1 MAP1A KIF21A TUBA1B MTOR PRKACA PRKACB RPS10P5 ARHGEF2	1.74e-05	621	150	12	22794259
Pubmed	The HIF-1 transcription complex is essential for translational control of myeloid hematopoietic cell function by maintaining mTOR phosphorylation.	HIF1A MTOR	1.85e-05	2	150	2	23872956
Pubmed	The human protein kinase gene PKX1 on Xp22.3 displays Xp/Yp homology and is a site of chromosomal instability.	PRKX PRKY	1.85e-05	2	150	2	7633447
Pubmed	Critical role for hypothalamic mTOR activity in energy balance.	TSC1 MTOR	1.85e-05	2	150	2	19356717
Pubmed	Rapamycin ameliorates corneal injury after alkali burn through methylation modification in mouse TSC1 and mTOR genes.	TSC1 MTOR	1.85e-05	2	150	2	33352197
Pubmed	Evidence for a second isoform of the catalytic subunit of cAMP-dependent protein kinase.	PRKACA PRKACB	1.85e-05	2	150	2	3023318
Pubmed	Aerobic Glycolysis Induced by mTOR/HIF-1α Promotes Early Brain Injury After Subarachnoid Hemorrhage via Activating M1 Microglia.	HIF1A MTOR	1.85e-05	2	150	2	36385451
Pubmed	Immunohistochemical analysis of the mechanistic target of rapamycin and hypoxia signalling pathways in basal cell carcinoma and trichoepithelioma.	HIF1A MTOR	1.85e-05	2	150	2	25181405
Pubmed	SPOP inhibits HBV transcription and replication by ubiquitination and degradation of HNF1α.	HIF1A SPOP	1.85e-05	2	150	2	38018242
Pubmed	Antitumor effects of low-dose tipifarnib on the mTOR signaling pathway and reactive oxygen species production in HIF-1α-expressing gastric cancer cells.	HIF1A MTOR	1.85e-05	2	150	2	33773069
Pubmed	TSC/MTOR mutated renal cell carcinoma with leiomyomatous stroma is a distinct entity: a comprehensive study of 12 cases.	TSC1 MTOR	1.85e-05	2	150	2	36592877
Pubmed	Overlapping retinal phenotypes in a consanguineous family harboring mutations in CRB1 and RS1.	RS1 CRB1	1.85e-05	2	150	2	30608181
Pubmed	Man to mouse--lessons learned from the distal end of the human X chromosome.	PRKX PRKY	1.85e-05	2	150	2	9414316
Pubmed	Prognostic implication of TSC1 and mTOR expression in gastric carcinoma.	TSC1 MTOR	1.85e-05	2	150	2	24615476
Pubmed	Profiles of PrKX expression in developmental mouse embryo and human tissues.	PRKX PRKY	1.85e-05	2	150	2	15879576
Pubmed	Selective Response to Mammalian Target of Rapamycin Inhibition in a Patient with Metastatic Renal Cell Carcinoma Bearing TSC1 Mutation.	TSC1 MTOR	1.85e-05	2	150	2	25796537
Pubmed	HIF1α Regulates mTOR Signaling and Viability of Prostate Cancer Stem Cells.	HIF1A MTOR	1.85e-05	2	150	2	25349289
Pubmed	Regulation of hypoxia-inducible factor 1alpha expression and function by the mammalian target of rapamycin.	HIF1A MTOR	1.85e-05	2	150	2	12242281
Pubmed	Association of thymidylate synthase and hypoxia inducible factor-1alpha DNA polymorphisms with pancreatic cancer.	HIF1A TYMS	1.85e-05	2	150	2	22825513
Pubmed	Investigation of -PRKACA/-PRKACB fusion genes in oncocytic tumors of the pancreatobiliary and other systems.	PRKACA PRKACB	1.85e-05	2	150	2	36152045
Pubmed	PRKACA/PRKACB Fusions in Pancreatobiliary Intraductal Oncocytic Papillary Neoplasms Including Those With Atypical Morphology: An Analysis of 22 Cases Expanding Morphologic Spectrum.	PRKACA PRKACB	1.85e-05	2	150	2	38841868
Pubmed	Selective Tuberous Sclerosis Complex 1 Gene Deletion in Smooth Muscle Activates Mammalian Target of Rapamycin Signaling and Induces Pulmonary Hypertension.	TSC1 MTOR	1.85e-05	2	150	2	26991739
Pubmed	Mammalian target of rapamycin complex 1 activation in podocytes promotes cellular crescent formation.	TSC1 MTOR	1.85e-05	2	150	2	24990893
Pubmed	Protein kinase A-dependent phosphorylation stimulates the transcriptional activity of hypoxia-inducible factor 1.	HIF1A PRKACA	1.85e-05	2	150	2	27245613
Pubmed	Hypoxia-inducible factor 1a is a Tsc1-regulated survival factor in newborn neurons in tuberous sclerosis complex.	HIF1A TSC1	1.85e-05	2	150	2	23349360
Pubmed	Epistasis between polymorphisms in ACVR2B and ADAMTS19 is associated with premature ovarian failure.	ADAMTS19 ACVR2B	1.85e-05	2	150	2	25051287
Pubmed	Molecular and behavioral effects of a null mutation in all PKA C beta isoforms.	PRKACA PRKACB	1.85e-05	2	150	2	12139926
Pubmed	PRKX critically regulates endothelial cell proliferation, migration, and vascular-like structure formation.	PRKX PRKY	1.85e-05	2	150	2	21684272
Pubmed	Abnormal XY interchange between a novel isolated protein kinase gene, PRKY, and its homologue, PRKX, accounts for one third of all (Y+)XX males and (Y-)XY females.	PRKX PRKY	1.85e-05	2	150	2	9302280
Pubmed	Hypoxia promotes noncanonical autophagy in nucleus pulposus cells independent of MTOR and HIF1A signaling.	HIF1A MTOR	1.85e-05	2	150	2	27314664
Pubmed	Effect of Primary Letrozole Treatment on Tumor Expression of mTOR and HIF-1α and Relation to Clinical Response.	HIF1A MTOR	1.85e-05	2	150	2	26063890
Pubmed	Characterization of genomic clones coding for the C alpha and C beta subunits of mouse cAMP-dependent protein kinase.	PRKACA PRKACB	1.85e-05	2	150	2	2833513
Pubmed	A novel peptide relieves endothelial cell dysfunction in preeclampsia by regulating the PI3K/mTOR/HIF1α pathway.	HIF1A MTOR	1.85e-05	2	150	2	33236147
Pubmed	mTOR regulation and therapeutic rejuvenation of aging hematopoietic stem cells.	TSC1 MTOR	1.85e-05	2	150	2	19934433
Pubmed	Increased levels of tyrosinated alpha-, beta(III)-, and beta(IV)-tubulin isotypes in paclitaxel-resistant MCF-7 breast cancer cells.	TUBA4A TUBA1B	1.85e-05	2	150	2	12054644
Pubmed	mRNA 3'-UTR shortening is a molecular signature of mTORC1 activation.	TSC1 MTOR	1.85e-05	2	150	2	26074333
Pubmed	Characterization of the microtubule-binding domain of microtubule-associated protein 1A and its effects on microtubule dynamics.	MAP1A TUBA4A	1.85e-05	2	150	2	9593747
Pubmed	mTOR signaling disruption from myeloid-derived suppressive cells protects against immune-mediated hepatic injury through the HIF1α-dependent glycolytic pathway.	HIF1A MTOR	1.85e-05	2	150	2	27462101
Pubmed	Hypoxia-inducible factor determines sensitivity to inhibitors of mTOR in kidney cancer.	HIF1A MTOR	1.85e-05	2	150	2	16341243
Pubmed	Global consequences of activation loop phosphorylation on protein kinase A.	PRKACA PRKACB	1.85e-05	2	150	2	19965870
Pubmed	Burn-induced muscle metabolic derangements and mitochondrial dysfunction are associated with activation of HIF-1α and mTORC1: Role of protein farnesylation.	HIF1A MTOR	1.85e-05	2	150	2	28747716
Pubmed	Characterization of the cAMP-dependent protein kinase catalytic subunit Cgamma expressed and purified from sf9 cells.	PRKACA PRKACG	1.85e-05	2	150	2	15039079
Pubmed	Protein kinase A translocation and insulin secretion in pancreatic beta-cells: studies with adenylate cyclase toxin from Bordetella pertussis.	PRKACA PRKACB	1.85e-05	2	150	2	12180908
Pubmed	Loss of tuberous sclerosis complex 1 (Tsc1) expression results in increased Rheb/S6K pathway signaling important for astrocyte cell size regulation.	TSC1 MTOR	1.85e-05	2	150	2	15185396
Pubmed	Expression of Wnt4 in human pituitary adenomas regulates activation of the beta-catenin-independent pathway.	WNT4 FZD6	1.85e-05	2	150	2	19034702
Pubmed	mTORC1 Activation Promotes Spermatogonial Differentiation and Causes Subfertility in Mice.	TSC1 MTOR	1.85e-05	2	150	2	27605345
Pubmed	Activation of mTORC1 in collecting ducts causes hyperkalemia.	TSC1 MTOR	1.85e-05	2	150	2	24203997
Pubmed	Recurrent Rearrangements in PRKACA and PRKACB in Intraductal Oncocytic Papillary Neoplasms of the Pancreas and Bile Duct.	PRKACA PRKACB	1.85e-05	2	150	2	31678302
Pubmed	Hypoxia: Turning vessels into vassals of cancer immunotolerance.	HIF1A MTOR	1.85e-05	2	150	2	32470491
Pubmed	Protein synthesis in plasma cells is regulated by crosstalk between endoplasmic reticulum stress and mTOR signaling.	TSC1 MTOR	1.85e-05	2	150	2	21268018
Pubmed	Systems-level identification of PKA-dependent signaling in epithelial cells.	PRKACA PRKACB	1.85e-05	2	150	2	28973931
Pubmed	Critical roles for the TSC-mTOR pathway in β-cell function.	TSC1 MTOR	1.85e-05	2	150	2	19690069
Pubmed	TSC-mTOR maintains quiescence and function of hematopoietic stem cells by repressing mitochondrial biogenesis and reactive oxygen species.	TSC1 MTOR	1.85e-05	2	150	2	18809716
Pubmed	Gene Rearrangement and Expression of PRKACA and PRKACB Govern Morphobiology of Pancreatobiliary Oncocytic Neoplasms.	PRKACA PRKACB	1.85e-05	2	150	2	37871652
Pubmed	Hypoxia promotes EV secretion by impairing lysosomal homeostasis in HNSCC through negative regulation of ATP6V1A by HIF-1α.	ATP6V1A HIF1A	1.85e-05	2	150	2	36748335
Pubmed	TSC/MTOR -associated Eosinophilic Renal Tumors Exhibit a Heterogeneous Clinicopathologic Spectrum : Several Distinct Entities or a Tumor Family?	TSC1 MTOR	1.85e-05	2	150	2	36727758
Pubmed	A novel murine PKA-related protein kinase involved in neuronal differentiation.	PRKX PRKY	1.85e-05	2	150	2	10729225
Pubmed	Phosphorylation of APOBEC3G by protein kinase A regulates its interaction with HIV-1 Vif.	PRKACA PRKACB PRKACG	2.18e-05	13	150	3	18836454
Pubmed	Viral genetic determinants of nonprogressive HIV type 1 subtype C infection in antiretroviral drug-naive children.	PRKACA PRKACB PRKACG	2.18e-05	13	150	3	19895210
Pubmed	The HIV-1 matrix protein p17 activates the transcription factors c-Myc and CREB in human B cells.	PRKACA PRKACB PRKACG	2.18e-05	13	150	3	20402410
Pubmed	Protein kinase A phosphorylation activates Vpr-induced cell cycle arrest during human immunodeficiency virus type 1 infection.	PRKACA PRKACB PRKACG	2.18e-05	13	150	3	20392842
Pubmed	Genome-wide CRISPR screen identifies HNRNPL as a prostate cancer dependency regulating RNA splicing.	ZNF704 APH1B ATP6V1A HIF1A ERV3-1 FOXN3 WNT4 PPM1K ACVR2B BRWD3 PLEKHH1 SETD5 PRKACB KIAA1328 PLEKHA2 KATNIP SH3RF3 PRKX GNL3	2.39e-05	1489	150	19	28611215
Pubmed	cAMP-dependent protein kinase: framework for a diverse family of regulatory enzymes.	PRKACA PRKACB PRKACG	3.44e-05	15	150	3	2165385
Pubmed	Gain of Additional BIRC3 Protein Functions through 3'-UTR-Mediated Protein Complex Formation.	THOC1 ATP6V1A HK1 ERO1A RPS20 MAST2 TBL3 TUBA1B UBE2O SAFB MTOR PRKACA CSTF1 CPSF1 TAF5L IK VARS1 GNL3	4.53e-05	1425	150	18	30948266
Pubmed	KCTD13-mediated ubiquitination and degradation of GluN1 regulates excitatory synaptic transmission and seizure susceptibility.	ATP6V1A PDE2A HK1 MAP1A TSC1 RPS20 TUBA4A CADM2 UBE2O SAFB LRIG1 PRKACA OGDHL RPS10P5 ARHGEF2 CORO7 VARS1 SEC13	4.78e-05	1431	150	18	37142655
Pubmed	Multiple APOBEC3 restriction factors for HIV-1 and one Vif to rule them all.	PRKACA PRKACB PRKACG	5.12e-05	17	150	3	24189052
Pubmed	Tuberous sclerosis complex proteins 1 and 2 control serum-dependent translation in a TOP-dependent and -independent manner.	TSC1 MTOR	5.53e-05	3	150	2	17562867
Pubmed	The Akt/mTOR pathway assures the synthesis of HIF-1alpha protein in a glucose- and reoxygenation-dependent manner in irradiated tumors.	HIF1A MTOR	5.53e-05	3	150	2	19098000
Pubmed	Differential dependence of hypoxia-inducible factors 1 alpha and 2 alpha on mTORC1 and mTORC2.	HIF1A MTOR	5.53e-05	3	150	2	18945681
Pubmed	Resveratrol inhibits hypoxia-driven ROS-induced invasive and migratory ability of pancreatic cancer cells via suppression of the Hedgehog signaling pathway.	HIF1A PLAU	5.53e-05	3	150	2	26707376
Pubmed	miR-130a upregulates mTOR pathway by targeting TSC1 and is transactivated by NF-κB in high-grade serous ovarian carcinoma.	TSC1 MTOR	5.53e-05	3	150	2	28800130
Pubmed	PKA regulates vacuolar H+-ATPase localization and activity via direct phosphorylation of the a subunit in kidney cells.	ATP6V1A PRKACA	5.53e-05	3	150	2	20525692
Pubmed	Tubulin is an inherent component of mitochondrial membranes that interacts with the voltage-dependent anion channel.	TUBA4A TUBA1B	5.53e-05	3	150	2	12087096
Pubmed	Therapeutic strategy targeting the mTOR-HIF-1alpha-VEGF pathway in ovarian clear cell adenocarcinoma.	HIF1A MTOR	5.53e-05	3	150	2	19121088
Pubmed	Up-regulation of two actin-associated proteins prompts pulmonary artery smooth muscle cell migration under hypoxia.	HIF1A CAPG	5.53e-05	3	150	2	19188659
Pubmed	Pathogenesis of tuberous sclerosis subependymal giant cell astrocytomas: biallelic inactivation of TSC1 or TSC2 leads to mTOR activation.	TSC1 MTOR	5.53e-05	3	150	2	15624760
Interaction	PKIG interactions	TYMS PRKACA PRKACB PRKACG	1.18e-06	12	144	4	int:PKIG
Cytoband	1q31-q32.1	F13B CRB1	1.06e-05	2	150	2	1q31-q32.1
Cytoband	Xp22.13	RS1 ADGRG2	2.93e-04	8	150	2	Xp22.13
Cytoband	17q24	ABCA10 ABCA8	4.69e-04	10	150	2	17q24
Cytoband	Ensembl 112 genes in cytogenetic band chrXp22	SUPT20HL1 SUPT20HL2 RS1 ADGRG2 PRKX	1.43e-03	250	150	5	chrXp22
Cytoband	10q22	HK1 GRID1	1.57e-03	18	150	2	10q22
Cytoband	Ensembl 112 genes in cytogenetic band chr3p25	WNT7A SLC6A6 SETD5 SEC13	1.73e-03	155	150	4	chr3p25
Cytoband	Ensembl 112 genes in cytogenetic band chr4q22	PPM1K TIGD2 HERC3	1.87e-03	74	150	3	chr4q22
Cytoband	18p11.32	THOC1 TYMS	1.94e-03	20	150	2	18p11.32
Cytoband	Xp22.11	SUPT20HL1 SUPT20HL2	2.14e-03	21	150	2	Xp22.11
Cytoband	1q21-q22	FCRL3 ARHGEF2	2.56e-03	23	150	2	1q21-q22
Cytoband	15q15.3	MAP1A ZSCAN29	3.03e-03	25	150	2	15q15.3
Cytoband	4q22.1	PPM1K TIGD2	3.27e-03	26	150	2	4q22.1
GeneFamily	WD repeat domain containing	IFT172 KIF21A EML6 TBL3 BRWD3 TLE2 CSTF1 TAF5L CORO7 ATG16L2 SEC13	1.15e-07	262	94	11	362
GeneFamily	C2-set domain containing\|Immunoglobulin like domain containing\|Scavenger receptors	STAB2 SSC4D LY75	3.64e-04	27	94	3	1253
GeneFamily	Adhesion G protein-coupled receptors, subfamily G	ADGRG5 ADGRG2	5.52e-04	7	94	2	917
GeneFamily	C-type lectin domain family	CLEC5A CLEC3B LY75	1.87e-03	47	94	3	494
GeneFamily	ATP binding cassette subfamily A	ABCA10 ABCA8	2.34e-03	14	94	2	805
Coexpression	BOYLAN_MULTIPLE_MYELOMA_C_UP	PDE2A TYMS LRIG1 MTOR CSTF1	9.26e-06	50	148	5	M847
Coexpression	BOYLAN_MULTIPLE_MYELOMA_C_UP	PDE2A TYMS LRIG1 MTOR CSTF1	9.26e-06	50	148	5	MM789
Coexpression	GSE22886_TH1_VS_TH2_48H_ACT_DN	CLGN FOXN3 TIPRL TRIM5 LRIG1 HERC3 TAF5L PRKX	1.89e-05	200	148	8	M4512
ToppCell	Bronchial-10x5prime-Stromal-Peri/Epineurial_-NAF_endoneurial\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MAP1A MUC5B ABCA10 ABCA8 PTH1R SLCO1C1 PWWP3B COL1A2	3.86e-07	200	149	8	29054cf55e88e1ac81a562d8dd9af9b7c749321d
ToppCell	TCGA-Liver-Primary_Tumor-Hepatocellular_Carcinoma-Hepatocellular_Carcinoma-8\|TCGA-Liver / Sample_Type by Project: Shred V9	F13B SIAE SCUBE1 TIGD2 OGDHL CLEC3B XAF1	1.80e-06	171	149	7	c4a919fe3d56ae6df2fcab6686abacc10befc053
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4-T_CD4/CD8\|lymph-node_spleen / Manually curated celltypes from each tissue	RAPGEF6 HIPK1 SYCN SYTL3 CRYBG1 DTHD1 PRKY	1.80e-06	171	149	7	2e9a20f8980b78325c52065a9c14ab3656267c05
ToppCell	5'-GW_trimst-1.5-LargeIntestine-Neuronal-Glial_immature-cycling_ENCC/glia\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CLGN KIF21A ABCA8 CRB1 TYMS TUBA1B CCNB2	2.63e-06	181	149	7	f2ebeb4941510c4b6e50f2379c574d1778d6ced1
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo\|lymph-node_spleen / Manually curated celltypes from each tissue	KIF21A TYMS SYTL3 CCNB2 GZMK PRKACB DTHD1	3.63e-06	190	149	7	4225bfa10a6fb909a3ba8ac26f3541c390b46737
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-type_I_NK_T_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KIF21A FCRL3 SYTL3 GZMK PRKACB CRYBG1 DTHD1	4.30e-06	195	149	7	0a72b8446399807ace5b6c72f865bb40dbd9e92d
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG5 KIF21A FCRL3 SYTL3 GZMK PRKACB DTHD1	4.60e-06	197	149	7	a44501cac24c2f4a53b413e92bd060eed6514616
ToppCell	mild-gd_T\|World / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	KIF21A FCRL3 SYTL3 GZMK PRKACB XAF1 DTHD1	5.08e-06	200	149	7	109f673a4967ffa52270a0b4f818b3461288db44
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ENOX1 GRID1 ABCA10 ABCA8 DLC1 SH3RF3 COL1A2	5.08e-06	200	149	7	58b38f9a484ee94191091a0659ed62ebed2d4a14
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-precursor_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS19 MUC5B DSCAML1 CADM2 CRB1 DTHD1	1.66e-05	160	149	6	c381ec6be8cf887861cc18f831a20db42f953fe1
ToppCell	facs-Marrow-B-cells-24m-Lymphocytic-pre_B_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ADAMTS19 MUC5B DSCAML1 CADM2 CRB1 DTHD1	1.66e-05	160	149	6	25c8f3d2a6d14ff0ca0b965fce89d3ff22f40585
ToppCell	facs-Pancreas-Endocrine-24m-Epithelial-pancreatic_PP_cell\|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	TBL3 CADM2 DNASE2B SYTL3 ANGPT4 PMFBP1	1.91e-05	164	149	6	74a35ba77e93d864161beb6b133d654473981bb7
ToppCell	facs-Large_Intestine-Proximal-3m-Epithelial-Brush_cell_of_epithelium_proper_of_large_intestine\|Large_Intestine / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation	MAP1A DSCAML1 FMO6P ADGRG2 NEURL1 OGDHL	2.34e-05	170	149	6	17bd7fd25a2657cb536ad47e294332920f759e95
ToppCell	3'_v3-Lung-Lymphocytic_T_CD4/8-lo\|Lung / Manually curated celltypes from each tissue	KIF21A TUBA4A TYMS SYTL3 GZMK DTHD1	2.42e-05	171	149	6	dfd4a15ab68ef5a9a1954b1b1540ae04017885a6
ToppCell	facs-Brain_Myeloid-Cerebellum-24m-Myeloid-microglial_cell\|Brain_Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	ERV3-1 CAPG RPS20 TUBA4A CCNB2 ANGPT4	2.58e-05	173	149	6	ef862e1d626bbc33191b433f483addff7f75ba16
ToppCell	3'-GW_trimst-1.5-SmallIntestine-Neuronal-neuron_precursor\|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract	CLGN KIF21A CADM2 CRB1 OGDHL ZNF124	2.75e-05	175	149	6	2ce8bcf9926862e723219b4246388428d0c3fdee
ToppCell	NS-moderate-d_07-13-Epithelial-Ionocyte\|d_07-13 / Location, Severity, dps_group, Lineage and Cell class of Upper airway (combined)	ATP6V1A NEURL1 OSBPL1A OGDHL CLEC3B FAM43A	2.94e-05	177	149	6	99500aed584f793aaf308f8afbf5d1c6a9b4ee55
ToppCell	droplet-Heart-4Chambers-18m-Endothelial-endothelial_cell_of_coronary_artery\|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A PLPP6 SLC6A6 DLC1 OGDHL FAM43A	3.03e-05	178	149	6	93ce73f8bcec63ebf86fabb546f88400e8f06465
ToppCell	Brain_organoid-organoid_Kanton_Nature-Organoid-4M-Neuronal-ventral_progenitors_and_neurons_2\|Organoid-4M / Sample Type, Dataset, Time_group, and Cell type.	MUC5B FOXN3 TUBA1B CCNB2 PRKX COL1A2	3.13e-05	179	149	6	d95367d689732ab2653e8d70d8d8e5eb15ae6eef
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A CLEC5A ERO1A CCNB2 PLAU LY75	3.33e-05	181	149	6	566249e04dd491e6287ad2101b7b1ab11031ed8b
ToppCell	facs-Marrow-Granulocytes-3m-Myeloid-granulocytopoietic_cell\|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	PDE2A CLEC5A ERO1A CCNB2 PLAU LY75	3.33e-05	181	149	6	db9528dc7cb0230e4c36cb27da69102c588c7ee9
ToppCell	3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo\|bone_marrow / Manually curated celltypes from each tissue	KIF21A TUBA4A SYTL3 GZMK PRKACB DTHD1	3.54e-05	183	149	6	2fb78622adc170dd3301e251418337523de50faf
ToppCell	3'_v3-bone_marrow-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|bone_marrow / Manually curated celltypes from each tissue	KIF21A TUBA4A SYTL3 GZMK PRKACB DTHD1	3.54e-05	183	149	6	37db007cc65005bffc18a5fda7f454a57c9fb0a9
ToppCell	IPF-Lymphoid-ILC_A\|IPF / Disease state, Lineage and Cell class	SYTL3 GZMK CRYBG1 PLEKHA2 PRKX PRKY	3.54e-05	183	149	6	49bfeaae13eb236f61a5486ee75c39789936bb8a
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-thymocyte\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB2 GRID1 MUC5B DSCAML1 CADM2 LOXHD1	3.65e-05	184	149	6	2cbed6462fea2622871bb7e49b0df3d984239281
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB2 GRID1 MUC5B DSCAML1 CADM2 LOXHD1	3.65e-05	184	149	6	ea7a7e2bac46d4d2c31a5d576b38a032b5335062
ToppCell	facs-Thymus-Thymus_Epithelium-18m-Lymphocytic-proliferating_thymocyte;_DN_to_DP_transition,_dividing_(some_are_Cd8+/_Cd4+,_some_undergoing_VDJ_recombination)\|Thymus / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	STAB2 GRID1 MUC5B DSCAML1 CADM2 LOXHD1	3.65e-05	184	149	6	2b19a8c5f823e00812908b23e66bb4e563278aff
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KIF21A TUBA4A SYTL3 GZMK PRKACB DTHD1	3.99e-05	187	149	6	b426a67b5669019115b58295ce7d304beeb75825
ToppCell	COPD-Lymphoid-NK\|COPD / Disease state, Lineage and Cell class	ADGRG5 FCRL3 SYTL3 PRKACB DTHD1 PRKX	4.11e-05	188	149	6	c9a227c8e71b69929d43e9afb8306a95c8163778
ToppCell	systemic_lupus_erythematosus-managed-Lymphocytic_T-CytoT_GZMK+-male\|systemic_lupus_erythematosus / PBMC cell types (v2) per disease, treatment status, and sex	KIF21A RPS20 TUBA4A SYTL3 GZMK DTHD1	4.11e-05	188	149	6	2513ca0efa73c09a3406b99e2876982d78b173d7
ToppCell	Fetal_29-31_weeks-Immune-natural_killer_cell\|Fetal_29-31_weeks / Lineage, Cell type, age group and donor	ADGRG5 FCRL3 SYTL3 GZMK DTHD1 PRKX	4.23e-05	189	149	6	c604da558c9f4055fb36218452463539f2a73223
ToppCell	3'_v3-lymph-node_spleen-Lymphocytic_T_CD4/8-lo-Tgd_CRTAM\|lymph-node_spleen / Manually curated celltypes from each tissue	KIF21A FCRL3 SYTL3 GZMK PRKACB DTHD1	4.23e-05	189	149	6	e8ff2c4fd2481bfbc99a5a6f02e0db8c995b3a23
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1-Pericyte\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ENOX1 GRID1 PTH1R DLC1 SLCO1C1 COL1A2	4.36e-05	190	149	6	4eb92aef1ee868f4537483d19014d947b7684612
ToppCell	nucseq-Mesenchymal-Myocytic-Myocytic_1\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	ENOX1 GRID1 PTH1R DLC1 SLCO1C1 COL1A2	4.36e-05	190	149	6	7be4341e2909101d756f14031c21e705eb45e69a
ToppCell	droplet-Spleen-nan-18m-Lymphocytic-B_cell\|Spleen / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAPG RPS20 CR2 PLEKHA2 VARS1 FAM43A	4.36e-05	190	149	6	ee7b60cdf93c695ea2d59a170ca8cf4dc93e7eb2
ToppCell	Brain_organoid-organoid_Paulsen_bioRxiv-3.5_mon-Neuronal-Immature_INs\|3.5_mon / Sample Type, Dataset, Time_group, and Cell type.	ZNF704 WNT7A DSCAML1 TLE2 PRKX COL1A2	4.36e-05	190	149	6	842760bfe0a52e67bad800efa7d99448a4a23ebb
ToppCell	10x5'-lymph-node_spleen-Lymphocytic_T_CD4/8-lo\|lymph-node_spleen / Manually curated celltypes from each tissue	KIF21A TUBA4A TYMS SYTL3 GZMK DTHD1	4.62e-05	192	149	6	4d72b9264ed62e0c08cde4078061b348253f6989
ToppCell	COPD-Lymphoid-T\|World / Disease state, Lineage and Cell class	RAPGEF6 TUBA4A LRIG1 SYTL3 CRYBG1 PRKX	4.62e-05	192	149	6	eb4909574fb5fc91399463523e2737095773200a
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG5 KIF21A FCRL3 SYTL3 GZMK DTHD1	4.62e-05	192	149	6	ce867b6e78c1d8f30dff81bf572a78a897bc7625
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_mature_gamma-delta_T_cell-T_gdT_c14-TRDV2\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG5 KIF21A FCRL3 SYTL3 GZMK DTHD1	4.62e-05	192	149	6	58a7829b411b02b422ef75e2277a868969cc23e8
ToppCell	Control-Lymphoid-T\|Control / Disease state, Lineage and Cell class	RAPGEF6 TUBA4A LRIG1 SYTL3 CRYBG1 PRKX	4.76e-05	193	149	6	af928046ccd1ca874be1534aef6ca7f27d90bc46
ToppCell	IPF-Lymphoid\|IPF / Disease state, Lineage and Cell class	ADGRG5 TUBA4A FCRL3 SYTL3 CRYBG1 PRKX	4.76e-05	193	149	6	bf9d50aea909a28dd1d0933af33842d5f1ae7818
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KIF21A FCRL3 SYTL3 GZMK PRKACB DTHD1	4.76e-05	193	149	6	523e2541f9f8d22b3c5263839a57cc1ab23d4963
ToppCell	3'-Pediatric_IBD-SmallIntestine-Hematopoietic-B_cells-STAT1+_Naive_B\|Pediatric_IBD / Celltypes from developing, pediatric, Crohn's, & adult GI tract	RPS20 PPM1K CR2 PLEKHA2 XAF1 PRKX	4.90e-05	194	149	6	a478947715e7ef7994040c7c661ff3a3e776b5fc
ToppCell	metastatic_Lymph_Node\|World / Location, Cell class and cell subclass	CLEC5A MUC5B PPM1K CR2 PLAU XAF1	4.90e-05	194	149	6	af6b5806238a610443564754367e91ce378c4a6d
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG5 KIF21A SYTL3 GZMK PRKACB DTHD1	4.90e-05	194	149	6	0fdf4d7d42d8f1f47eade2fb89ff35b188b9b51f
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	KIF21A FCRL3 SYTL3 GZMK PRKACB DTHD1	5.04e-05	195	149	6	42382653e977714bff453bece26a6cd66ea2cc1f
ToppCell	10x5'-Liver-Lymphocytic_T_CD4/8-lo\|Liver / Manually curated celltypes from each tissue	RPS20 TUBA4A SYTL3 PRKACB CRYBG1 DTHD1	5.04e-05	195	149	6	c29c4ae95a756e3ced0f0747bbfe343590e5b8ab
ToppCell	COPD-Lymphoid-T\|COPD / Disease state, Lineage and Cell class	RAPGEF6 TUBA4A LRIG1 SYTL3 CRYBG1 PRKX	5.18e-05	196	149	6	30e53b8050d2a041f855d0e39bbd8f923c64c489
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn-38\|World / Primary Cells by Cluster	ZNF704 EML6 RPS20 FOXN3 ARHGEF2 PRKX	5.18e-05	196	149	6	38da0751941adca650fe9b383d9f343153978eb5
ToppCell	Neuron-Postmitotic-Excitatory_Neuron_-IPC/newborn\|World / Primary Cells by Cluster	ZNF704 EML6 RPS20 FOXN3 ARHGEF2 PRKX	5.18e-05	196	149	6	721650a08d260faf530dbd52d4e9275d27f3bac2
ToppCell	Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_myofibroblast\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADAMTS19 ABCA10 ABCA8 DLC1 SH3RF3 COL1A2	5.33e-05	197	149	6	0dd71e399f253787fa546a7e90c5373180b89ffd
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP47 MAP1A IFT172 KIF21A IK DTHD1	5.33e-05	197	149	6	91637bdeab85024b5a02d1066f76cb803a2d6420
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP47 MAP1A IFT172 KIF21A IK DTHD1	5.33e-05	197	149	6	22c87dd15dc57bd0aa98a204c9fc9b3b9b573b45
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)-Multiciliated_(non-nasal)_L.0.3.0.0\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP47 MAP1A IFT172 KIF21A IK DTHD1	5.33e-05	197	149	6	3bbf068d2ad8196fbc85d3f311a7c54c9aece856
ToppCell	PBMC_fresh-frozen-Mild-Moderate_convalescent_d36-51-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c07-TYROBP\|Mild-Moderate_convalescent_d36-51 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG5 KIF21A FCRL3 SYTL3 PRKACB DTHD1	5.33e-05	197	149	6	2abe27f6722fa0dab801bca4cd19e34c1fb4173e
ToppCell	severe-Lymphocytic-NK_cells\|severe / Cohort 2 (Rhapsody WB + PBMC) with disease condition, lineage and cell classs	ADGRG5 RPS20 FCRL3 SYTL3 PRKACB DTHD1	5.33e-05	197	149	6	8bf88b10d49ac499e7d0ba5b7023909e1fd7b29a
ToppCell	5'-Airway_Nasal-Epithelial-Airway_ciliated-ciliated_columnar_cell_of_tracheobronchial_tree-Multiciliated_(non-nasal)\|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5	CFAP47 MAP1A IFT172 KIF21A IK DTHD1	5.33e-05	197	149	6	87db09f341e2b20eb6e1c3e917cb5c960387b3e9
ToppCell	ASK440-Epithelial-Type_1\|Epithelial / Donor, Lineage and Cell class of Lung cells from Dropseq	WNT7A POLR2L RS1 ABCA8 FZD6 DLC1	5.33e-05	197	149	6	782449c522c9e16e72bf999a73090688a3aefe06
ToppCell	nucseq-Immune-Immune_Myeloid-Myeloid_Dendritic-cDC2\|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2	HIF1A CLEC5A ETV3 FOXN3 SYTL3 CRYBG1	5.33e-05	197	149	6	a902aa05e5f711bcfdd9e19749ab636b597eb116
ToppCell	PBMC_fresh-frozen-Severe-critical_convalescent_d42-56-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell\|Severe-critical_convalescent_d42-56 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG5 KIF21A SYTL3 GZMK PRKACB DTHD1	5.33e-05	197	149	6	35004d4728d33f15cc3be99a073b1ea965365c32
ToppCell	(02)_MMP9/10+-(1)_GFP\|(02)_MMP9/10+ / shred by cell type by condition	WNT7A MUC5B TUBA4A TUBA1B PLAU VARS1	5.64e-05	199	149	6	448ba982be804007f991d469eca9d885b21ae499
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZNF704 MAP1A ABCA8 CADM2 PLEKHH1 DLC1	5.64e-05	199	149	6	5d2e85e40b6b52b1809e680b952913d77215b3d0
ToppCell	Tracheal-NucSeq-Stromal-Peri/Epineurial_\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ABCA10 ABCA8 SCUBE1 DLC1 SLCO1C1 COL1A2	5.64e-05	199	149	6	3835452e4848d7f7dd8651c17b746b271ef39688
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZNF704 MAP1A ABCA8 CADM2 PLEKHH1 DLC1	5.64e-05	199	149	6	9dd4b17fb8c70ab9e126b23b72600463f3db832d
ToppCell	Bronchial-10x5prime-Stromal-Peri/Epineurial_\|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations	MUC5B ABCA10 ABCA8 SLCO1C1 PWWP3B COL1A2	5.64e-05	199	149	6	45c3b853900d8c3d5965117d904e3714100138bc
ToppCell	Tracheal-NucSeq-Stromal-Peri/Epineurial_-NAF_epineurial\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ENOX1 ABCA10 ABCA8 SCUBE1 SLCO1C1 COL1A2	5.64e-05	199	149	6	9c2db0bb94cba71a3cc1827844da090e213e0258
ToppCell	10x_3'_v3-spleen_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD8-positive,_alpha-beta_memory_T_cell\|spleen_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type	KIF21A TUBA4A SYTL3 GZMK CRYBG1 DTHD1	5.64e-05	199	149	6	69793ef363618030e4546877b3095c587617909f
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal-Oligodendrocyte-Oligodendrocyte-Z\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZNF704 MAP1A ABCA8 CADM2 PLEKHH1 DLC1	5.64e-05	199	149	6	6fb5f931e6217142de38c1fffc011e63bda4772b
ToppCell	10x_5'_v1-Non-neoplastic-Glial-Neuronal\|10x_5'_v1 / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group	ZNF704 MAP1A ABCA8 CADM2 PLEKHH1 DLC1	5.64e-05	199	149	6	1bb5797e8e0552bf9b44bf4c958d1aa6dbe6c756
ToppCell	mild-gd_T\|mild / Cohort 1 (10x PBMC) with disease condition, cell group and cell class	KIF21A FCRL3 SYTL3 GZMK PRKACB DTHD1	5.80e-05	200	149	6	2c21ede46a42b8e2f8e99ecca365baa52056eb17
ToppCell	Parenchymal-NucSeq-Immune_Lymphocytic-NK-ILC-T_NK-NK_CD56bright\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	ADGRG5 FCRL3 SYTL3 GZMK PLEKHA2 PRKX	5.80e-05	200	149	6	1db27223e307efca97502fca40ec5e4f8eea512b
ToppCell	Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GRID1 PTH1R DLC1 SLCO1C1 ANGPT4 COL1A2	5.80e-05	200	149	6	9d3ae9ea47b1017adb63aa02d10e98193d478458
ToppCell	Tracheal-NucSeq-Stromal-Pericyte\|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations	GRID1 PTH1R DLC1 SLCO1C1 ANGPT4 COL1A2	5.80e-05	200	149	6	78cd0b7d221ef855512ee9ac9a291f61622c2e24
ToppCell	Brain_organoid-organoid_Tanaka_cellReport-3m-Neuronal-Intermediate\|3m / Sample Type, Dataset, Time_group, and Cell type.	MAP1A PDCD2L CADM2 SH3RF3 SEC13 FAM43A	5.80e-05	200	149	6	cbd0b9188a94778ffa539912aeb2a4378f0ab88f
ToppCell	Severe-CD8+_T\|World / Disease group and Cell class	DSCAML1 FCRL3 GZMK DTHD1	6.29e-05	64	149	4	3e7ede6ec5d8b9c4fc6f3aa8fda91fd9b763ef18
ToppCell	COVID-19_Severe-dn_T\|COVID-19_Severe / Disease condition and Cell class	ZNF704 CAPG SLCO1C1 GZMK DTHD1	1.16e-04	142	149	5	2008033881b9e1b20926c3508d6ebdb6f1a1528f
ToppCell	renal_medulla_nuclei-CKD+DKD_normotensive-Epithelial-Collecting_tubule_epithelial_cell-kidney_collecting_duct_principal_cell-Outer_Medullary_Collecting_Duct_Principal_Cell\|CKD+DKD_normotensive / Celltypes from Cells and Nuclei per compartment and clinical group	EML6 C4orf54 TIGD2 CCNB2 PLEKHA2	1.36e-04	147	149	5	b66ccc710b3c04f6fc7fed69f3c892fc110e98fc
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells-Ciliated\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	C8orf89 MAP1A EML6 DTHD1 FBXO15	1.69e-04	154	149	5	9ca71d440c4f87781e6525b8141e7d8d470b6a8e
ToppCell	LPS_only-Epithelial_airway-Ciliated_cells\|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2	C8orf89 MAP1A EML6 DTHD1 FBXO15	1.69e-04	154	149	5	58072ce422d09f2de602580325eaac6c4ec6c136
ToppCell	5'-Adult-Appendix-Hematopoietic-B_cells-Cycling_B_cell\|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract	EML6 CR2 FCRL3 OR13A1 PLEKHA2	1.80e-04	156	149	5	203ef22eb76bd2b829b027c30af0557080f4006c
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Endothelial-Endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAPG RPS20 SLC6A6 DLC1 SLCO1C1	1.91e-04	158	149	5	ba9998cbf786c515d30fe42de02c7a246db1b6f9
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Endothelial-endothelial_cell\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAPG RPS20 SLC6A6 DLC1 SLCO1C1	1.91e-04	158	149	5	a2efcc184ef13d81373e3690253ba35f6be09c5f
ToppCell	facs-Brain_Non-Myeloid-Cortex-24m-Endothelial\|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAPG RPS20 SLC6A6 DLC1 SLCO1C1	1.91e-04	158	149	5	e52eff2bd1e7e0ce9c278ed5109802865e0fe69c
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA10 ABCA8 DLC1 TLE2 COL1A2	1.96e-04	159	149	5	e812cbde59188924c6277c3feadf1a9592fa62a4
ToppCell	renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-Collagen-high_Fibroblast\|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA10 ABCA8 DLC1 TLE2 COL1A2	1.96e-04	159	149	5	2607b562903228274fbd96168ba826782fab0b53
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast-\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA8 DLC1 SLCO1C1 TLE2 COL1A2	2.14e-04	162	149	5	5f009b231f21861afee9cc0c569082e1135f929c
ToppCell	renal_cortex_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-high_Fibroblast\|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group	ABCA8 DLC1 SLCO1C1 TLE2 COL1A2	2.14e-04	162	149	5	b936f8040dcd4db621ccded19237af8df7d0ed6e
ToppCell	343B-Lymphocytic-NK_cells-NK_cell_D3\|343B / Donor, Lineage, Cell class and subclass (all cells)	ADGRG5 CAPG TUBA4A GZMK FAM43A	2.20e-04	163	149	5	8a4931c9fdaedcf6c319157821d3556cd25fc9e5
ToppCell	AT1_cells-IPF_04\|World / lung cells shred on cell class, cell subclass, sample id	ADGRG5 WNT7A RS1 CLEC3B	2.37e-04	90	149	4	6cbf30dd3992d8ccfaa74ad9781b9f8735f1ef69
ToppCell	TCGA-Lung-Solid_Tissue_Normal\|TCGA-Lung / Sample_Type by Project: Shred V9	RS1 ABCA8 SCUBE1 ANGPT4 CLEC3B	2.40e-04	166	149	5	a8ebdd3cb7f59b3feeaacda45ce6d40d10db556f
ToppCell	TCGA-Lung-Solid_Tissue_Normal-Lung\|TCGA-Lung / Sample_Type by Project: Shred V9	RS1 ABCA8 SCUBE1 ANGPT4 CLEC3B	2.40e-04	166	149	5	c64971c27cb445dffc5a636d4b6a60261b93a2db
ToppCell	TCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue\|TCGA-Lung / Sample_Type by Project: Shred V9	RS1 ABCA8 SCUBE1 ANGPT4 CLEC3B	2.40e-04	166	149	5	2f3072a7af048f184d33065fdd36153fd563155a
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d03-09-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c06-TNF\|Severe-critical_progression_d03-09 / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG5 KIF21A PPM1K CADM2 DTHD1	2.40e-04	166	149	5	217e0549f88819d02156ea64e8547b658b1c7aef
ToppCell	TCGA-Lung-Solid_Tissue_Normal-Lung-Lung_normal_tissue-6\|TCGA-Lung / Sample_Type by Project: Shred V9	RS1 ABCA8 SCUBE1 ANGPT4 CLEC3B	2.40e-04	166	149	5	188f2575511f418216874aed9118aa6f165252cb
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1A GRID1 DLC1 SH3RF3 COL1A2	2.47e-04	167	149	5	e228b8373ffd4436e6b944e26d0fadf3ac289b21
ToppCell	renal_papilla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Myocytic_interstitial_cell-Vascular_Smooth_Muscle_Cell_/_Pericyte\|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group	MAP1A GRID1 DLC1 SH3RF3 COL1A2	2.47e-04	167	149	5	7cb1b11e8e24a10115e46ffbb74889e672a7a026
ToppCell	BALF-PFMC-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ZNF41 SYTL3 CCNB2 GZMK PRKACB	2.47e-04	167	149	5	063ec29b32e40aaa138a691da3a79ee8eef0c2be
ToppCell	PBMC_fresh-frozen-Severe-critical_progression_d12-22_no-steroids-Lymphocytic-Lymphocytic_T-CD8-positive,_alpha-beta_T_cell-T_CD8_c03-GZMK\|Severe-critical_progression_d12-22_no-steroids / Compartment, severity and other cell annotations on 10x 3' data (130k)	ADGRG5 KIF21A SYTL3 GZMK DTHD1	2.47e-04	167	149	5	abc4ba308ca3be41b0da604f5d82579fd58dff7b
ToppCell	facs-Lung-EPCAM-24m-Lymphocytic-B_cell\|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation	CAPG RPS20 CR2 LOXHD1 FBXO15	2.47e-04	167	149	5	691f3589de0f8c13f9137812cfa9040c07d237b4
Disease	urinary bladder cancer (implicated_via_orthology)	HK1 TYMS PLAU	8.97e-06	9	142	3	DOID:11054 (implicated_via_orthology)
Disease	Focal Cortical Dysplasia of Taylor, Type IIb	TSC1 MTOR	6.88e-05	3	142	2	C1846389
Disease	FOCAL CORTICAL DYSPLASIA OF TAYLOR	TSC1 MTOR	6.88e-05	3	142	2	C1846385
Disease	Focal Cortical Dysplasia of Taylor, Type IIa	TSC1 MTOR	6.88e-05	3	142	2	C1846386
Disease	Isolated focal cortical dysplasia type II	TSC1 MTOR	6.88e-05	3	142	2	cv:C1846385
Disease	FOCAL CORTICAL DYSPLASIA, TYPE II	TSC1 MTOR	6.88e-05	3	142	2	607341
Disease	Usual Interstitial Pneumonia	HIF1A MUC5B PLAU	9.99e-05	19	142	3	C4721509
Disease	Hamman-Rich Disease	HIF1A MUC5B PLAU	9.99e-05	19	142	3	C4721508
Disease	Familial Idiopathic Pulmonary Fibrosis	HIF1A MUC5B PLAU	1.17e-04	20	142	3	C4721952
Disease	Idiopathic Pulmonary Fibrosis	HIF1A MUC5B PLAU	1.36e-04	21	142	3	C1800706
Disease	acute kidney failure (implicated_via_orthology)	HIF1A WNT4 MTOR	2.93e-04	27	142	3	DOID:3021 (implicated_via_orthology)
Disease	Colorectal Neoplasms	GRID1 ABCA10 ABCA8 TYMS DLC1 NEURL1 XAF1	4.03e-04	277	142	7	C0009404
Disease	heparin cofactor 2 measurement	DLC1 PMFBP1	4.75e-04	7	142	2	EFO_0008150
Disease	microlissencephaly (implicated_via_orthology)	TUBA4A TUBA1B	6.32e-04	8	142	2	DOID:0112234 (implicated_via_orthology)
Disease	lissencephaly 3 (implicated_via_orthology)	TUBA4A TUBA1B	6.32e-04	8	142	2	DOID:0112232 (implicated_via_orthology)
Disease	polymicrogyria (implicated_via_orthology)	TUBA4A TUBA1B	6.32e-04	8	142	2	DOID:0080918 (implicated_via_orthology)
Disease	gestational age, parental genotype effect measurement	DDX31 WNT4 VARS1	6.38e-04	35	142	3	EFO_0005112, EFO_0005939
Disease	polybrominated biphenyl measurement, gestational serum measurement, fetal genotype effect measurement, polybrominated diphenyl ether measurement	TRIM5 LOXHD1	1.23e-03	11	142	2	EFO_0007959, EFO_0007961, EFO_0007962, EFO_0007964
Disease	Ductal Carcinoma	HIF1A SPOP	1.23e-03	11	142	2	C1176475
Disease	urokinase-type plasminogen activator measurement	PLAU LY75	1.23e-03	11	142	2	EFO_0010803
Disease	beta wave measurement	C8orf89 OSBPL1A	1.47e-03	12	142	2	EFO_0006871
Disease	male infertility (implicated_via_orthology)	CFAP47 PMFBP1	1.73e-03	13	142	2	DOID:12336 (implicated_via_orthology)
Disease	phospholipids in very small VLDL measurement	ABCA10 TRIM5 PMFBP1	1.92e-03	51	142	3	EFO_0022300
Disease	Neoplasm of uncertain or unknown behavior of bladder	TSC1 MTOR	2.32e-03	15	142	2	C0496930
Disease	Benign neoplasm of bladder	TSC1 MTOR	2.32e-03	15	142	2	C0154017
Disease	Carcinoma in situ of bladder	TSC1 MTOR	2.32e-03	15	142	2	C0154091
Disease	complement factor H-related protein 1 measurement	F13B CRB1 CENPVL3	2.51e-03	56	142	3	EFO_0600054
Disease	Cannabis use	ZNF704 CADM2	2.64e-03	16	142	2	EFO_0007585
Disease	autosomal recessive polycystic kidney disease (implicated_via_orthology)	TSC1 MTOR	2.64e-03	16	142	2	DOID:0110861 (implicated_via_orthology)
Disease	ferritin measurement	HK1 WNT4 KIAA1328 GNL3	2.66e-03	119	142	4	EFO_0004459
Disease	Myopia	APH1B ENOX1 DSCAML1 KIAA1328 KATNIP DDX60L SH3RF3	2.69e-03	385	142	7	HP_0000545
Disease	sinusitis (is_marker_for)	MUC5B PLAU	3.35e-03	18	142	2	DOID:0050127 (is_marker_for)
Disease	Female Urogenital Diseases	WNT7A WNT4	3.35e-03	18	142	2	C1720887
Disease	Carcinoma of bladder	TSC1 MTOR	3.35e-03	18	142	2	C0699885
Disease	polycystic kidney disease (biomarker_via_orthology)	HIF1A MTOR	3.73e-03	19	142	2	DOID:0080322 (biomarker_via_orthology)
Disease	ovarian neoplasm	WNT7A TYMS DLC1 MTOR	4.07e-03	134	142	4	C0919267
Disease	Malignant neoplasm of ovary	WNT7A TYMS DLC1 MTOR	4.40e-03	137	142	4	C1140680
Disease	Deep Vein Thrombosis	F13B PLAU	4.55e-03	21	142	2	C0149871
Disease	haptoglobin measurement	DLC1 PMFBP1	4.55e-03	21	142	2	EFO_0004640
Disease	Venous Thrombosis	F13B PLAU	4.55e-03	21	142	2	C0042487
Disease	status epilepticus (implicated_via_orthology)	MTOR PLAU	4.55e-03	21	142	2	DOID:1824 (implicated_via_orthology)

Protein segments in the cluster

Peptide	Gene	Start	Entry
WAFLAAGGSCRSLKL	APH1B	226	Q8WW43
LNWKNCKGITSDGTA	FAM200B	286	P0CF97
IGKFCIARWGKAFTD	ERV3-1	341	Q14264
RADGFKCGSDWTKAV	ATG16L2	541	Q8NAA4
CAGSSLFLKRKWGIG	ABCA10	606	Q8WWZ4
DGCLLWKTATGRFKD	ARHGEF2	476	Q92974
ARELSKSGKFLWNGS	ETV3	486	P41162
TSLRSGTKCKVTGWG	GZMK	141	P49863
CGKLRLAENSDWSKT	ADGRG2	896	Q8IZP9
GSCLIFESSWKKAVL	C8orf89	21	P0DMQ9
LRDAKDCKSTLWNGS	BRWD3	106	Q6RI45
KGVQLSDWRDGVCTK	MUC5B	676	Q9HC84
RIKKCGGFVAWNSLG	PPM1K	236	Q8N3J5
LGKWCKAGECTSRTS	ADAMTS19	616	Q8TE59
TDFTKWLGREGLCKV	KIN	116	O60870
LGWTKKDLCSTNGGF	LTN1	1151	O94822
FGFAKRVKGRTWTLC	PRKACA	186	P17612
LVDGGSDRKSCFWKL	MAP1A	61	P78559
KRGWTDTSQPGCFSK	KIAA0895	426	Q8NCT3
NISKLTDGAFWGLSK	LRIG1	246	Q96JA1
ISWKFECGSVGLKVD	NGLY1	551	Q96IV0
LGRGTFGQVAKCWKR	HIPK1	196	Q86Z02
SWKRVKGCKSSEQNG	HIF1A	751	Q16665
SSAACWNGSFLEKKI	HERC3	431	Q15034
NRNLAGKKDSSPWTC	KATNIP	531	O60303
ATIFNCGRWLDKKRG	LOXHD1	2041	Q8IVV2
LLVTCLGVKSFKWGQ	DDX60L	46	Q5H9U9
CRGATEGLSKKSVVW	CPSF1	1316	Q10570
WSRDGALVGTACKDK	CORO7	176	P57737
LRGSKISRCEQGKWS	F13B	431	P05160
WCFLSELIKKSSGGS	FAM86B1	71	Q8N7N1
ARKWSSEKRFGLEGC	OGDHL	256	Q9ULD0
STGGARSWKVFRSQC	PDCD2L	86	Q9BRP1
SCDLSDQTKGWKTTR	PDE2A	806	O00408
QLFKKWRDCPSGFSV	LMLN2	316	A0A1B0GTW7
FVKWENKSKSGVGRC	LY75	1621	O60449
SGIKKCPSFLVTGQW	FMO6P	111	O60774
VLTRDDCFKGKRWGA	DDX31	661	Q9H8H2
DINCKGRSKSNLGWT	OSBPL1A	36	Q9BXW6
LITWTKGFKATDCVG	HK1	616	P19367
NCDGWLLGTSSSIKK	KIAA1328	416	Q86T90
KVRDSGNSGLAEKCW	IFT172	1301	Q9UG01
RVPSTKGRWKAFSTC	OR1F2P	226	Q96R84
CVGSKFWEQSVRLGS	GBA	381	P04062
VGISAVFWVGSKKTC	FZD6	486	O60353
TVLVDGCSKKTNEWG	COL1A2	1311	P08123
FGFAKRVKGRTWTLC	PRKACB	186	P22694
FGFAKRVKGRTWTLC	PRKACG	186	P22612
GEKIINCLSSGKWSA	CR2	191	P20023
SQKGTKNRWTCIGDL	DNASE2B	311	Q8WZ79
AASCLSQKVLGQGKW	CCNB2	311	O95067
SERSFKLDSLKCGTW	DSCAML1	1436	Q8TD84
KVGLSWKTDIFDGCI	FBXO15	406	Q8NCQ5
DKERSQSIGKGSLWC	FOXN3	176	O00409
FRKLWGLSCEGAAKV	CENPVL3	106	A0A0U1RRI6
DTGCTGWNKTQGKDR	CENPJ	511	Q9HC77
CKTSGSKPAADIRWF	CADM2	146	Q8N3J6
WKQFLKRGSKCSETS	C6orf50	51	Q9HD87
RKVFCDLQSSGGRWT	ANGPT4	316	Q9Y264
ESKSSWKRVSFGRCS	CEP95	146	Q96GE4
KLLGFRSQDSGWCGL	DTHD1	441	Q6ZMT9
KCRLWGKLQTQGLGT	ERO1A	396	Q96HE7
DGCTDLAVGKIWSKS	FAM43A	86	Q8N2R8
WSTAFKGEKVALICS	FCRL3	31	Q96P31
CKLWRGNLASSLSGK	MAST2	96	Q6P0Q8
KDGKWSFCADTRISA	ELSPBP1	161	Q96BH3
WKLLGGFQETCSKAI	GNL3	241	Q9BVP2
KLATWDSEKGLNGSL	GRID1	411	Q9ULK0
AWCGGKSNILERNKA	CAPG	176	P40121
FWTLCGNALTAKRGI	EML6	176	Q6ZMW3
SFEDWGGKNCKISSV	CRYBG1	1386	Q9Y4K1
GSSLNVKAGCVRKDW	CRB1	661	P82279
SKDGCIKLWDGVSNR	CSTF1	281	Q05048
WSTFLDLKCGGVGAR	C4orf54	661	D6RIA3
WNGKDCVETGKCLSR	SCUBE1	396	Q8IWY4
WTLDLSNTGKLFKDG	CFAP47	1231	Q6ZTR5
FTGVGATLEKRWKLC	ENOX1	621	Q8TC92
VKTAWGRQKAFSTCS	OR13A1	246	Q8NGR1
CGSLSRSTGFLKWKD	REG3G	146	Q6UW15
VNLWGPKKTISFLGC	OR2H1	81	Q9GZK4
RTWLKYASLCGKSGR	MTOR	1651	P42345
ESTQREKVCGTLGWK	PMFBP1	966	Q8TBY8
RFASGGCDNLIKLWK	SEC13	181	P55735
KSGYCVKQGNVRKSW	PLEKHA2	201	Q9HB19
RKTPCGEGSKTWDRF	RPS20	66	P60866
GGDACSLSKLQWQKV	SYTL3	581	Q4VX76
LKKLGSSLDWDRACF	VARS1	431	P26640
GFDNSCIKLWSLRSK	TAF5L	286	O75529
GGLTRFTDQLGKLWC	XAB2	246	Q9HCS7
TGIVSWGRGCALKDK	PLAU	391	P00749
CGQCKGSLERKSWTS	RAPGEF6	1421	Q8TEU7
CFFCIWKGVRSTGKV	SLC6A6	231	P31641
LNIAKAGSCVDTWKG	SUPT20HL1	281	Q3ZLR7
GTKGSRWLKSFLNAN	PWWP3B	576	Q5H9M0
VLDFAGCTKNITAWK	TAF1A	336	Q15573
CRNKKGAWTLAGVTS	OVCH2	246	Q7RTZ1
FGFAKKLVDRTWTLC	PRKY	191	O43930
LLPDGTFSSCKKRWI	SETD5	771	Q9C0A6
WSSGRSLKACGVPKQ	SIAE	226	Q9HAT2
PCAISGKWTFQRDSK	DLC1	531	Q96QB1
KEEKGRSSCGRNFWV	SAFB	396	Q15424
LNITKAGSCVDTWKG	SUPT20HL2	281	P0C7V6
IFRKGRKNSGIWSFC	ABCA8	1126	O94911
TLTCVFWKEGARKQP	ADGRG5	186	Q8IZF4
SSGTIELVKKGCWLD	ACVR2B	66	Q13705
FDSGRLAGWVLSKAK	CLGN	66	O14967
SWNESRDFCKGKGST	CLEC5A	91	Q9NY25
SKKTAWILGVCAGFQ	TRIM5	366	Q9C035
ADQTGLFWKCLPSRT	TIGD2	176	Q4W5G0
DIFGRLSSWCLKKPG	TSC1	156	Q92574
TKKQCCWSGALRLGF	NEURL1	111	O76050
SLKSRGCVKEQFAWR	RPS10P5	51	Q9NQ39
LANTGCWDLSSGNKK	PTH1R	346	Q03431
TTAAWAAGKKSGRLR	SSC4D	331	Q8WTU2
LSGAANGKWFDKRCR	CLEC3B	176	P05452
FTGSKDRTCKVWNLV	KIF21A	1361	Q7Z4S6
LFSGSRDNGIKKWDL	KIF21A	1556	Q7Z4S6
KCQDGWFKGASLRTG	SH3RF3	496	Q8TEJ3
RDFCFGPWKLTASKT	TIPRL	11	O75663
TFSSGANDKLKWCLR	SPOP	56	O43791
RKGWLFASCAKDQSV	TBL3	386	Q12788
LIDTSCLKWGFKRCG	SLCO1C1	611	Q9NYB5
CRWLASSKGKQVRNF	XAF1	286	Q6GPH4
NGKVCVSLLGTWIGK	UBE2O	1036	Q9C0C9
CNEWGKALSGKSSLF	ZNF137P	46	P52743
LSSKGVKIWDANGSR	TYMS	101	P04818
DGNTKCFISGWGRTK	TMPRSS12	201	Q86WS5
AWKTLQGSELSVKCG	STAB2	1831	Q8WWQ8
IKWDFTPCKNLRVGS	ATP6V1A	131	P38606
LIKSINEKFAGSAGW	IK	406	Q13123
RCFTCGKIVGNKWEA	POLR2L	6	P62875
FGFAKKLVDRTWTLC	PRKX	191	P51817
KLLTFRCSSASWGEG	PLEKHH1	271	Q9ULM0
LWLSKKLGVCAGESS	PLPP6	111	Q8IY26
LWKNCGKVLSTAAGI	ZNF704	196	Q6ZNC4
QKCGKAFSRASTLWK	ZNF124	321	Q15973
GWTTKTFRIAKCQSD	TMEM87B	411	Q96K49
GDCGKTFTWKSRLNI	ZNF41	736	P51814
SCFIEWGLPGTKNKT	ZMYM5	136	Q9UJ78
KCRECGKAFRWSSNL	ZNF445	791	P59923
RWNCSALGERTVFGK	WNT7A	81	O00755
KQCGKTFSWSETLRV	ZNF57	311	Q68EA5
RWNCSTLDSLPVFGK	WNT4	86	P56705
CELTVWSRQGKAGKT	SYCN	86	Q0VAF6
CRSGRQWAKTSGEKR	ZSCAN29	611	Q8IWY8
GKSFGWASCLLKHQR	ZNF224	546	Q9NZL3
KSTDIWQGCLRKSCG	XKR5	321	Q6UX68
ARLNSQGFGCAWLSK	RS1	101	O15537
KTKRSIQFVDWCPTG	TUBA1B	336	P68363
SCGRWFVSTGKDNLL	TLE2	681	Q04725
KCEESGKAFIWSSGL	ZNF726P1	131	Q15940
WLKNVSRAGVSGCFS	THAP11	36	Q96EK4
KTKRSIQFVDWCPTG	TUBA4A	336	P68366
WKNEGCPSFVKERTS	THOC1	391	Q96FV9
NCKECGKSFRWASGI	ZNF284	456	Q2VY69
KECGKTFSWGSSLVK	ZNF283	266	Q8N7M2